Inhibition of activated protein C and its cofactor protein S by antiphospholipid antibodies
- 1 September 1990
- journal article
- research article
- Published by Wiley in British Journal of Haematology
- Vol. 76 (1) , 101-107
- https://doi.org/10.1111/j.1365-2141.1990.tb07843.x
Abstract
Summary. We have investigated the effects of purified IgG fractions from plasma containing the lupus anticoagulant (LAC) and/or IgG anticardiolipin antibody (ACA) on the degradation of factor Va by an activated protein C‐protein S complex. Plasma samples from 10 patients were studied. LAC was detected by a Russell's Viper venom technique. ACA was determined by ELISA. IgG fractions were obtained from each plasma sample by protein A‐Sepharose fractionation. This fraction was shown to exhibit ACAILAC activity. Using purified activated protein C (APC), protein S and phosphati‐dylserine/phosphatidylcholine, factor Va degradation was assessed in the presence and absence of IgG fractions from LAC/ACA containing plasmas. After 2 min incubation the mean factor Va degradation by APC and protein S in the presence of IgG LAC/ACA fractions was 14% compared with 52% with normal IgG. A similar effect was seen when phospholipid was substituted by washed freeze‐thawed platelets. Experiments employing varying concentrations of protein S and phospholipid revealed marked differences in respect of the inhibitory specificity of the different antiphospholipid antibodies. These results indicate that antiphospholipid antibodies have an inhibitory effect on the activated protein C/protein S complex and provide some explanation for a relationship between antiphospholipid antibodies and thrombosis.This publication has 26 references indexed in Scilit:
- The effect of phospholipids on the activation of protein C by the human thrombin-thrombomodulin complexBiochemical Journal, 1986
- Lupus anticoagulant: An analysis of the clinical and laboratory features of 219 casesAmerican Journal of Hematology, 1985
- Protein S and the Regulation of Activated Protein CSeminars in Thrombosis and Hemostasis, 1984
- Lupus anticoagulant in pregnancyBJOG: An International Journal of Obstetrics and Gynaecology, 1984
- Structure and Function of Protein CSeminars in Thrombosis and Hemostasis, 1984
- Thrombosis in systemic lupus erythematosus: striking association with the presence of circulating lupus anticoagulant.BMJ, 1983
- Factor Va-factor Xa interaction. Effects of phospholipid vesicles of varying compositionBiochemistry, 1982
- ARTERIAL THROMBOSIS, INTRAUTERINE DEATH AND "LUPUS" ANTICOAGULANT: DETECTION OF IMMUNOGLOBULIN INTERFERING WITH PROSTACYCLIN FORMATIONThe Lancet, 1981
- POSSIBLE RELATIONSHIP BETWEEN LUPUS INHIBITOR AND RECURRENT ABORTION IN YOUNG WOMENThe Lancet, 1980
- INTRAUTERINE DEATH AND CIRCULATING ANTICOAGULANT (“ANTITHROMBOPLASTIN”)Acta Medica Scandinavica, 1975